Eczema

ORLANDO — A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic hand eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of Dermatology Annual Meeting.

ORLANDO — Treatment-experienced patients with moderate to severe atopic dermatitis attained higher efficacy rates on rocatinlimab compared with placebo, according to a presenter at the American Academy of Dermatology Annual Meeting

ORLANDO — Nutrition plays a role in the management of atopic dermatitis, according to research presented at the American Academy of Dermatology Annual Meeting.

SAN DIEGO — Across six different situations, more allergists preferred second- vs. first-generation antihistamines; however, in five situations, at least 18% reported preference for both antihistamines, according to a poster presented here.

The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has been cleared by the FDA, Alphyn Biologics announced in a press release.

Researchers have discovered significant links between total serum IgE in children with food allergy and several patient factors, according to results published in The Journal of Allergy and Clinical Immunology: In Practice.

Long-term treatment with lebrikizumab may be beneficial for patients with atopic dermatitis that were not initially responders to the treatment, according to a study.

The Wall Street Journal has published an article labeling dermatology as the “it” job in medicine due to seemingly glamorous perks, prompting a defense from the American Academy of Dermatology.

BOSTON — Managing food allergies should involve more than just allergen avoidance, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

The year 2024 was important for skin disorders with many innovations and breakthroughs.